Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals
Open accessAbstract
How dystrophic neurites form around amyloid plaques is a key aspect of understanding the early pathophysiology of Alzheimer's disease. At present, three hypotheses prevail: (1) dystrophies result from extracellular amyloid-beta (Aβ) toxicity; (2) dystrophies results from accumulation of Aβ into distal neurites; and (3) dystrophies represent blebbing of the somatic membrane of a neuron with high Aβ load. We utilized a unique feature of the common 5xFAD AD mouse model to test these hypotheses. Cortical layer 5 pyramidal neurons show intracellular APP and Aβ accumulation before amyloid plaque formation while dentate granule cells in these mice show no APP accumulation at any age. However, the dentate gyrus shows amyloid plaques by 3 months of age. By a careful confocal microscopic analysis we found no evidence of severe degeneration in amyloid laden layer 5 pyramidal neurons in contrast to hypothesis 3. Using injecting red fluorescent marker into lateral entorhinal projection neurons in 5xFAD mice with endogenous green fluorescent protein (GFP) in dentate granule cells we could demonstrate that all dystrophies is outer molecular layer originate from the axon terminal of entorhinal projection neurons. Immunostaining with vesicular glutamate transporter supported the axonal nature of the dystrophies in the acellular dentate molecular layer. We observed few small dystrophies in the GFP labeled granule cell dendrites. In general GFP labeled dendrites appear normal around the amyloid…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
APP is a marker of axonal degeneration and accumulates in presynaptic terminals, indicative of dystrophic neurons surrounding amyloid plaques.
“Previous studies have established APP as a marker of axonal degeneration54,55 and demonstrated its accumulation in presynaptic terminals, indicative of dystrophic neurons surrounding amyloid plaques.56”
From Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease (2025) · cites this paper as [54]
The reduced number of dystrophic neurites indicates decreased β-amyloid-driven axonal damage.
“indicative of decreased β-amyloid-driven axonal damage [44–47]”
From The protective PLCγ2-P522R variant mitigates Alzheimer’s disease-associated pathologies by enhancing beneficial microglial functions (2025) · cites this paper as [47]
PLD3 levels are negatively correlated with Aβ and cognitive function.
“PLD3 levels have been reported to be negatively correlated with Aβ and cognitive function, 21 , 34”
From The MR1/MAIT cell axis enhances dystrophic neurite development in Alzheimer's disease (2025) · cites this paper as [34]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 25 · Cited by 27
- Authors
- Mabrouk, R., Miettinen, P. O., & Tanila, H.
- Affiliations
- University of Eastern Finland (FI)
- Corresponding author
- Tanila, H.
- ORCID
- Tanila, H.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2023-06
- Volume
- 182
- Pages
- 106150
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W4376643367
- Cited by
- 27
- References
- 25
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 7 · 2023: 2
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neurobiology of Disease (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- dystrophic neurites, Alzheimer's disease, amyloid plaques, amyloid-beta toxicity, 5xFAD mice, axon terminals, dentate gyrus, pyramidal neurons, vesicular glutamate transporter, dendrites, axonal degeneration
- MeSH terms
- Alzheimer Disease, Animals, Disease Models, Animal, Mice, Transgenic, Amyloid beta-Peptides, Neurites, Amyloid beta-Protein Precursor, Presynaptic Terminals, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review